Figure 9
From: Besifloxacin liposomes with positively charged additives for an improved topical ocular delivery

Scheme of possible dispositions of the besifloxacin in LP PC (A,B) and LP PC: SPM (C,D), according to the characteristics and the method of preparation of each liposome.